Latest market price
19.75
-0.05-0.25%
OverviewShort InterestFilings
SLNQT60Silence Therapeutics plc·NASDAQ
19.75-0.25%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 19, 20268-KCurrent report
Oct 19, 2026DEFA14AAdditional proxy soliciting materials
Oct 19, 2026DEFA14AAdditional proxy soliciting materials
Oct 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 12, 2026424B5Prospectus
Aug 12, 20268-KCurrent report
Aug 11, 2026S-3MEFS-3MEF
Aug 10, 20268-KCurrent report
Aug 10, 202610-QQuarterly report
Aug 10, 2026424B5Prospectus
Aug 10, 20268-KCurrent report
Jul 16, 20268-K/ACurrent report (amended)
Jul 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 07, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 11, 20268-KCurrent report
May 27, 2026424B5Prospectus
May 27, 2026EFFECTNotice of effectiveness
May 18, 20268-KCurrent report
May 18, 2026S-3Shelf registration statement
#1 / 25 of 208
Page
▼
/ 9